The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients
Xiaochen Ma, Xiangyang Sun, Fubo Xie, Wencheng Jian, Qingliang Wang, Yang Xie, Caixia Li, Kai Zhang Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, People’s Republic of ChinaCorrespondence: Kai Zhang, Department of Radiology, Qilu Hospital of Shandong University, Jina...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-03-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/the-influence-of-drug-eluting-beads-transarterial-chemoembolization-on-peer-reviewed-fulltext-article-JHC |
| _version_ | 1827308329846702080 |
|---|---|
| author | Ma X Sun X Xie F Jian W Wang Q Xie Y Li C Zhang K |
| author_facet | Ma X Sun X Xie F Jian W Wang Q Xie Y Li C Zhang K |
| author_sort | Ma X |
| collection | DOAJ |
| description | Xiaochen Ma, Xiangyang Sun, Fubo Xie, Wencheng Jian, Qingliang Wang, Yang Xie, Caixia Li, Kai Zhang Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, People’s Republic of ChinaCorrespondence: Kai Zhang, Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, People’s Republic of China, Email zhangkai@qiluhospital.comAim: This study aims to explore the role of soluble programmed cell death protein 1 (sPD-1) in individuals with hepatocellular carcinoma (HCC) undergoing treatment with drug-eluting beads transarterial chemoembolization (D-TACE). Additionally, we aim to assess the potential utility of sPD-1 for determining the optimal timing for combining D-TACE with immune checkpoint inhibitors (ICIs).Materials and Methods: A total of 44 HCC patients eligible for D-TACE and 55 healthy volunteers were enrolled in this study. Three milliliters of peripheral venous blood from the patients were collected on the day before D-TACE and 3, 7, and 30 days after D-TACE, respectively, for the assay of sPD-1. The relationships between sPD-1 levels, clinical features, outcomes, and the fluctuation of sPD-1 during treatment were analyzed.Results: The initial sPD-1 levels in patients were found to be significantly higher than those in the control group. Although the initial sPD-1 levels displayed a decreasing trend with an increase in BCLC stage, no significant differences were observed among patients at different BCLC stages. The sPD-1 level on day 3 after D-TACE was similar to that on day 7 after D-TACE and significantly lower than the initial level. The sPD-1 level on day 30 after D-TACE was significantly higher than that on day 3 and day 7 after D-TACE and nearly returned to the initial level before D-TACE.Conclusion: The level of sPD-1 was found to be significantly elevated in patients with HCC. However, further research is deemed necessary to fully understand the role of sPD-1 as a potential biomarker in the initiation, progression, and prognosis of HCC. The decrease in sPD-1 following D-TACE suggests that immune effector cells might potentially be reduced, as well as immune function weakened, highlighting the need to avoid the prompt administration of ICIs after D-TACE.Keywords: hepatocellular carcinoma, immunotherapy, soluble programmed cell death protein 1, drug-eluting beads transarterial chemoembolization |
| first_indexed | 2024-04-24T18:56:32Z |
| format | Article |
| id | doaj.art-afe5901930e24292bd9ae99b4f39d460 |
| institution | Directory Open Access Journal |
| issn | 2253-5969 |
| language | English |
| last_indexed | 2024-04-24T18:56:32Z |
| publishDate | 2024-03-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Journal of Hepatocellular Carcinoma |
| spelling | doaj.art-afe5901930e24292bd9ae99b4f39d4602024-03-26T17:28:02ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692024-03-01Volume 1161962891509The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma PatientsMa XSun XXie FJian WWang QXie YLi CZhang KXiaochen Ma, Xiangyang Sun, Fubo Xie, Wencheng Jian, Qingliang Wang, Yang Xie, Caixia Li, Kai Zhang Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, People’s Republic of ChinaCorrespondence: Kai Zhang, Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, People’s Republic of China, Email zhangkai@qiluhospital.comAim: This study aims to explore the role of soluble programmed cell death protein 1 (sPD-1) in individuals with hepatocellular carcinoma (HCC) undergoing treatment with drug-eluting beads transarterial chemoembolization (D-TACE). Additionally, we aim to assess the potential utility of sPD-1 for determining the optimal timing for combining D-TACE with immune checkpoint inhibitors (ICIs).Materials and Methods: A total of 44 HCC patients eligible for D-TACE and 55 healthy volunteers were enrolled in this study. Three milliliters of peripheral venous blood from the patients were collected on the day before D-TACE and 3, 7, and 30 days after D-TACE, respectively, for the assay of sPD-1. The relationships between sPD-1 levels, clinical features, outcomes, and the fluctuation of sPD-1 during treatment were analyzed.Results: The initial sPD-1 levels in patients were found to be significantly higher than those in the control group. Although the initial sPD-1 levels displayed a decreasing trend with an increase in BCLC stage, no significant differences were observed among patients at different BCLC stages. The sPD-1 level on day 3 after D-TACE was similar to that on day 7 after D-TACE and significantly lower than the initial level. The sPD-1 level on day 30 after D-TACE was significantly higher than that on day 3 and day 7 after D-TACE and nearly returned to the initial level before D-TACE.Conclusion: The level of sPD-1 was found to be significantly elevated in patients with HCC. However, further research is deemed necessary to fully understand the role of sPD-1 as a potential biomarker in the initiation, progression, and prognosis of HCC. The decrease in sPD-1 following D-TACE suggests that immune effector cells might potentially be reduced, as well as immune function weakened, highlighting the need to avoid the prompt administration of ICIs after D-TACE.Keywords: hepatocellular carcinoma, immunotherapy, soluble programmed cell death protein 1, drug-eluting beads transarterial chemoembolizationhttps://www.dovepress.com/the-influence-of-drug-eluting-beads-transarterial-chemoembolization-on-peer-reviewed-fulltext-article-JHChepatocellular carcinomaimmunotherapysoluble programmed cell death protein 1drug-eluting beads transarterial chemoembolization |
| spellingShingle | Ma X Sun X Xie F Jian W Wang Q Xie Y Li C Zhang K The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients Journal of Hepatocellular Carcinoma hepatocellular carcinoma immunotherapy soluble programmed cell death protein 1 drug-eluting beads transarterial chemoembolization |
| title | The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients |
| title_full | The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients |
| title_fullStr | The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients |
| title_full_unstemmed | The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients |
| title_short | The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients |
| title_sort | influence of drug eluting beads transarterial chemoembolization on serum levels of soluble programmed cell death protein 1 in advanced hepatocellular carcinoma patients |
| topic | hepatocellular carcinoma immunotherapy soluble programmed cell death protein 1 drug-eluting beads transarterial chemoembolization |
| url | https://www.dovepress.com/the-influence-of-drug-eluting-beads-transarterial-chemoembolization-on-peer-reviewed-fulltext-article-JHC |
| work_keys_str_mv | AT max theinfluenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT sunx theinfluenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT xief theinfluenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT jianw theinfluenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT wangq theinfluenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT xiey theinfluenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT lic theinfluenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT zhangk theinfluenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT max influenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT sunx influenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT xief influenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT jianw influenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT wangq influenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT xiey influenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT lic influenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients AT zhangk influenceofdrugelutingbeadstransarterialchemoembolizationonserumlevelsofsolubleprogrammedcelldeathprotein1inadvancedhepatocellularcarcinomapatients |